口腔微生物组和动脉样硬化:有关关联,机制和临床影响的当前证据
Yan Xiao1,2, Bin Gong1,2, Jing Li1,2
1Oral Medicine Center, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China.
Frontiers in immunology
|October 31, 2025
概括
口腔微生物组显著影响心血管疾病 (CVD),超出了传统的风险因素. 本综述探讨了针对个性化心血管疾病预防的新机制和未来临床策略.
科学领域:
- 心血管科学 心血管科学
- 微生物组研究 微生物组研究
- 免疫学 免疫学 免疫学
背景情况:
- 动脉样硬化,一个关键的心血管疾病 (CVD) 病理,并不能完全解释传统的风险因素.
- 口腔微生物组越来越多地被认为是导致心血管疾病的重要环境贡献者.
- 现有证据将口腔微生物组与心血管疾病联系起来,需要进行批判性评估和机械洞察.
研究的目的:
- 批判地评估口腔微生物组在心血管疾病中的作用的证据.
- 综合对口腔微生物组-心血管疾病病变的新型机械洞察力.
- 概述未来的跨学科心血管疾病预防的临床框架.
主要方法:
- 建立和新兴机制的全面审查 (例如,细菌病,炎症,口腔-肠-血管轴,表观遗传重编程,多王国微生物组).
- 从观察性研究,门德尔随机化和随机对照试验 (RCT) 中获得的证据的批判性评估,解决方法异质性问题.
- 探索未来的方向,包括用于生物标志物发现和新型治疗干预的人工智能 (AI).
主要成果:
- 讨论了像细菌病和全身炎症这样的传统机制.
- 突出显示了新出现的路径,如口腔-肠-血管轴和表观遗传重编程.
- 系统地检查当前研究中的方法异质性,以协调相互矛盾的发现.
结论:
- 更深入地了解口腔微生物组在心血管疾病中的作用至关重要.
- 未来的研究应该专注于基于机制的,针对心血管疾病预防的个性化策略.
- 将科学共识转化为可操作的临床框架对于跨学科的患者护理至关重要.
相关概念视频
Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Atherosclerosis I: Introduction
868
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
868
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
452
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
452
Coronary Artery Disease I: Introduction
868
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
868
Coronary Artery Disease II: Pathophysiology
359
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
359
Atherosclerosis IV: Nursing Management
357
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
357


